For over three decades, HIV has played an elaborate game of hide-and-seek with researchers, making treating—and possibly even ...

What if the presence of a well-known but misunderstood viral protein explains why some people living with HIV (PLWH) never ...

A total of 10 individuals with HIV have been cured to date. Most of these patients have remained anonymous, but three have ...

Many vaccines work by introducing a protein to the body that resembles part of a virus. Ideally, the immune system will produce long-lasting antibodies recognizing that specific virus, thereby ...

HIV/AIDS remains a major public health threat worldwide, with an estimated 39.9 million people living with the disease at the ...

Researchers showed that people treated with fostemsavir have lower levels of “bad” antibodies produced in response to a HIV ...

Being out of care doesn’t have to be permanent, and many people can restart HIV treatment. The sooner PWH restart treatment, ...

For more than 20 years, the Duke Consortia for HIV/AIDS Vaccine Development had conducted its groundbreaking research with federal funding. Now it's looking toward private funding to continue its ...

Lymphoma is an aggressive cancer that starts in the lymphatic system and occurs more frequently in individuals living with HIV. HIV-related lymphoma begins in the lymphatic system, a vital part of the ...

This research roundup explores how immune system genetic activity can provide guidance into treatment options for patients ...